CLINICAL_TRIALS
trial_result
· 2011-11-16
Clinical Trial Update: Study to Assess VB-201 in Patients With Psoriasis [Phase 2]
Summary
A Phase 2 study evaluating VB-201 for active plaque psoriasis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vascular Biogenics Ltd. operating as VBL Therapeutics | Conditions: Active Plaque Psoriasis | Phase 2 | Status: COMPLETED